Hints and tips:
...It’s all very colourful though. 5) Fern Labs Inc ($1mn for 5 per cent stake) There’s a company called Fern Labs Inc based at 280 Smith St, Farmingdale, NY 11735, United States, roughly in the middle of...
...Disease Control and Prevention] are making it very difficult and putting a lot of requirements on cruise operators to operate out of the US,” said Nigel Thomas, chairman and maritime partner at the law firm Watson...
...Molloy set up and led the UK’s network of huge pop-up testing laboratories, dubbed “Lighthouse Labs”....
...ft_houseandhome on Instagram to find out about our latest stories first Letters in response to this article: Being carpet-bombed with blandness from both sides / From Marie Louise von Glinski, Astoria, NY...
...Watson Pharmaceuticals and Par Pharmaceutical have previously been prevented from working on a generic film alternative, but Indivior said the latest ruling means they “are now able to pursue their respective...
...The FTC also accused Endo of paying hundreds of millions of dollars in 2012 to Watson Laboratories, now part of Allergan, to delay the introduction of a generic version of Lidoderm, a shingles pain patch...
...In a forest in western Tokyo, Hitachi’s research laboratory is linked to the outside world by a path dubbed the “bridge for geeks”....
...SM began contesting the market for generics last year, introducing the Watsons Generics brand to compete with Unilab and Pascual Laboratories, the second-largest domestic drug manufacturer....
...Rather than funding early-stage research in its own laboratories, Mr Saunders said the company was employing an “open science” approach — buying or licensing drugs that have already been unearthed by smaller...
...Because Watson has the ability to learn, Ross refines its responses based on experience....
...It bought Watson Pharmaceuticals for $6bn (2012), Ireland-domiciled Warner Chilcott for $9bn (2013) and Forest Laboratories for $25bn (2014)....
...Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase to date....
...The $25bn purchase of Forest Laboratories, announced on Tuesday, is by far the largest transaction he has overseen so far....
...FT EVENING ROUND-UP Actavis buys Forest Laboratories for $25bn: “Actavis, the highly acquisitive Dublin-based drugs maker, has agreed to buy New York’s Forest Laboratories for $25bn, its biggest purchase...
...He has set up a company in San Diego called Human Longevity Inc or HLI, which “will build the largest human [DNA] sequencing operation in the world”....
...IBM is investing $1bn to build a business unit around Watson, its “cognitive computing” project....
...(Financial Times) Forest Labs nears $3 billion deal for Aptalis: “Forest Laboratories Inc (is nearing an agreement to acquire specialty pharmaceutical company Aptalis Holdings Inc from private equity firm...
...The FTSE 100 drugmaker’s shares fell as much as 13 per cent after the FDA granted approval for Watson Pharmaceuticals’ Actavis unit to produce a cut-price version of Adderall XR, one of Shire’s top-selling...
...But Pfizer is expected to generate about $500m in revenues and maintain a 40 per cent market share of Lipitor during the next six months, when Watson Pharmaceuticals and Ranbaxy will be its only competition...
...Ranbaxy Laboratories, an Indian drug company, and Watson Pharmaceuticals are the only companies with rights to sell generic Lipitor for the next six months, at which point other companies can enter the market...
...Shares of India’s biggest pharmaceutical company, Ranbaxy Laboratories, opened up 10.4 per cent on Thursday, following news that it had received FDA-approval to market its generic version of Pfizer’s anti-cholesterol...
...Wednesday should have been a great day for India’s largest pharmaceutical company, Ranbaxy Laboratories....
...The market’s disappointment over the results weighed on the healthcare sector with Watson Pharmaceuticals falling 1.2 per cent to $62.63 and Mylan losing 2.5 per cent to $24.23....
...Elsewhere in the sector, Forest Laboratories added 4.8 per cent to $34.74 and Watson Pharmaceutical rose 2.2 per cent to $63.36. The S&P healthcare index put on 1 per cent....
...The modern glass and metal building with its stacks of sophisticated laboratory equipment looks like the headquarters of a Californian biotechnology company, but it is in fact the new extension of the Liverpool...
International Edition